KPC Pharmaceuticals, Inc. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 4,093.071 million compared to CNY 3,424.130 million a year ago. Operating income was CNY 403.294 million compared to CNY 275.562 million a year ago. Net income was CNY 332.069 million compared to CNY 224.608 million a year ago. Basic earnings per share from continuing operations was CNY 0.4379 compared to CNY 0.2952 a year ago.